The global health burden ofthe major hemoglobin disorders, sickle cell anemia and B-thalassemia, is enormous and predicted to grow. Increased fetal hemoglobin (HbF) greatly ameliorates the morbidity and mortality of these disorders. A long sought goal is directed reactivation of HbF expression in adults with hemoglobin disorders. Largely through human genetic studies, substantial progress has been made in understanding the regulatory factors controlling the fetal (a2Y2) to adult (a2B2) switch and how HbF silencing is maintained in the adult. A premise of the proposed work is that fundamental findings on hemoglobin switching provide a platform for establishing mechanism-based approaches to the identification of small molecules that induce HbF in adult erythroid cells. If successful in this overall goal, new therapies may be developed for treatment of patients with the major hemoglobin disorders. This proposal encompasses three independent, but interrelated, aims. First, the mechanisms by which the gene encoding BCL11A, a central repressor of HbF expression, is regulated will be explored using high-resolution nascent transcription mapping, chromatin occupancy, and assays of putative cis-regulatory elements. Down-regulation of BCL11A expression or function provides a direct route to relief from HbF silencing. An additional goal of this aim isalso to determine how genetic variation in the BCL1 IA gene influences expression of BCL11A itself, as this knowledge may lead to approaches to direct down-regulation of BCL11A expression. Second, high throughput screening for small molecule inducers of HbF will be performed in cultured erythroid cells, and promising """"""""hits"""""""" will be evaluated further for the pathways affected and for optimization as therapeutics. Third, screens with genome-wide short hairpin RNA (shRNA) and open reading frame (ORF) libraries will be performed to identify novel genes/pathways for induction of silenced HbF in primary human CD34 derived erythroid progenitors. Through the multidisciplinary approaches in this proposal basic findings on HbF regulation will be translated to advance identification and development of new therapeutics for patients with hemoglobin disorders.
This project addresses the reactivation of fetal hemoglobin (HbF) in adult erythroid cells. The topic is directly relevant to human hemoglobin disorders, as reactivation of HbF would constitute an effective treatment strategy for affected individuals.
|Huang, Jialiang; Liu, Xin; Li, Dan et al. (2016) Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. Dev Cell 36:9-23|
|Canver, Matthew C; Orkin, Stuart H (2016) Customizing the genome as therapy for the Î²-hemoglobinopathies. Blood 127:2536-45|
|Gao, Xiaofei; Lee, Hsiang-Ying; da Rocha, Edroaldo Lummertz et al. (2016) TGF-Î² inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors. Blood 128:2637-2641|
|Shi, Jiahai; Yuan, Bingbing; Hu, Wenqian et al. (2016) JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways. Exp Hematol 44:1044-1058.e5|
|Hagedorn, Elliott J; Cillis, Jennifer L; Curley, Caitlyn R et al. (2016) Generation of Parabiotic Zebrafish Embryos by Surgical Fusion of Developing Blastulae. J Vis Exp :|
|Yien, Yvette Y; Paw, Barry H (2016) A role for iron deficiency in dopaminergic neurodegeneration. Proc Natl Acad Sci U S A 113:3417-8|
|Nasrallah, Rabab; Fast, Eva M; Solaimani, Parham et al. (2016) Identification of novel regulators of developmental hematopoiesis using Endoglin regulatory elements as molecular probes. Blood 128:1928-1939|
|Masuda, Takeshi; Wang, Xin; Maeda, Manami et al. (2016) Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science 351:285-9|
|CHARGE Consortium Hematology Working Group (2016) Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits. Nat Genet 48:867-76|
|Gao, Xin; Wu, Tongyu; Johnson, Kirby D et al. (2016) GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis. Stem Cell Reports 6:368-82|
Showing the most recent 10 out of 163 publications